223 related articles for article (PubMed ID: 31921468)
1. Human Immunity Against
Hameed A
Immune Netw; 2019 Dec; 19(6):e38. PubMed ID: 31921468
[No Abstract] [Full Text] [Related]
2. The immunobiology of Campylobacter jejuni: Innate immunity and autoimmune diseases.
Phongsisay V
Immunobiology; 2016 Apr; 221(4):535-43. PubMed ID: 26709064
[TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
4. Cytokine responses in campylobacteriosis: Linking pathogenesis to immunity.
Al-Banna NA; Cyprian F; Albert MJ
Cytokine Growth Factor Rev; 2018 Jun; 41():75-87. PubMed ID: 29550265
[TBL] [Abstract][Full Text] [Related]
5. Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni-infected intestinal epithelium.
Johanesen PA; Dwinell MB
Infect Immun; 2006 Jun; 74(6):3437-47. PubMed ID: 16714574
[TBL] [Abstract][Full Text] [Related]
6. Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome.
Nyati KK; Prasad KN
Mediators Inflamm; 2014; 2014():758639. PubMed ID: 25614713
[TBL] [Abstract][Full Text] [Related]
7. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3.
Zilbauer M; Dorrell N; Boughan PK; Harris A; Wren BW; Klein NJ; Bajaj-Elliott M
Infect Immun; 2005 Nov; 73(11):7281-9. PubMed ID: 16239524
[TBL] [Abstract][Full Text] [Related]
8. Innate immune responses play a key role in controlling infection of the intestinal epithelium by Cryptosporidium.
Laurent F; Lacroix-Lamandé S
Int J Parasitol; 2017 Oct; 47(12):711-721. PubMed ID: 28893638
[TBL] [Abstract][Full Text] [Related]
9. Novel Immunomodulatory Flagellin-Like Protein FlaC in Campylobacter jejuni and Other Campylobacterales.
Faber E; Gripp E; Maurischat S; Kaspers B; Tedin K; Menz S; Zuraw A; Kershaw O; Yang I; Rautenschlein S; Josenhans C
mSphere; 2016; 1(1):. PubMed ID: 27303676
[TBL] [Abstract][Full Text] [Related]
10. Novel Clinical
Mousavi S; Bereswill S; Heimesaat MM
Microorganisms; 2020 Mar; 8(4):. PubMed ID: 32231139
[No Abstract] [Full Text] [Related]
11. Innate and adaptive immune pathways to tolerance.
Thornton CA; Morgan G
Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
[TBL] [Abstract][Full Text] [Related]
12. Inflammasome in Dendritic Cells Immunobiology: Implications to Diseases and Therapeutic Strategies.
Ferreira I; Liberal J; Martins JD; Silva A; Neves BM; Cruz MT
Curr Drug Targets; 2017; 18(9):1003-1018. PubMed ID: 27660056
[TBL] [Abstract][Full Text] [Related]
13. A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni.
Zilbauer M; Dorrell N; Elmi A; Lindley KJ; Schüller S; Jones HE; Klein NJ; Núnez G; Wren BW; Bajaj-Elliott M
Cell Microbiol; 2007 Oct; 9(10):2404-16. PubMed ID: 17521327
[TBL] [Abstract][Full Text] [Related]
14. CapC, a Novel Autotransporter and Virulence Factor of Campylobacter jejuni.
Mehat JW; Park SF; van Vliet AHM; La Ragione RM
Appl Environ Microbiol; 2018 Aug; 84(16):. PubMed ID: 29915112
[No Abstract] [Full Text] [Related]
15. Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection.
Stahl M; Vallance BA
Gut Microbes; 2015; 6(2):143-8. PubMed ID: 25831043
[TBL] [Abstract][Full Text] [Related]
16. Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.
Brooks PT; Brakel KA; Bell JA; Bejcek CE; Gilpin T; Brudvig JM; Mansfield LS
Microbiome; 2017 Aug; 5(1):92. PubMed ID: 28789710
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic and proteomic analyses reveal key innate immune signatures in the host response to the gastrointestinal pathogen Campylobacter concisus.
Kaakoush NO; Deshpande NP; Man SM; Burgos-Portugal JA; Khattak FA; Raftery MJ; Wilkins MR; Mitchell HM
Infect Immun; 2015 Feb; 83(2):832-45. PubMed ID: 25486993
[TBL] [Abstract][Full Text] [Related]
18. Campylobacter jejuni-mediated disease pathogenesis: an update.
Zilbauer M; Dorrell N; Wren BW; Bajaj-Elliott M
Trans R Soc Trop Med Hyg; 2008 Feb; 102(2):123-9. PubMed ID: 18023831
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors recognize distinct proteinase-resistant glycoconjugates in Campylobacter jejuni and Escherichia coli.
Phongsisay V; Hara H; Fujimoto S
Mol Immunol; 2015 Mar; 64(1):195-203. PubMed ID: 25530156
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter Enteritis and the Guillain-Barré Syndrome.
Nachamkin I
Curr Infect Dis Rep; 2001 Apr; 3(2):116-122. PubMed ID: 11286651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
